Choosing the right metabolic monitoring device: a decision-maker's guide
10/03/2026
Device selection for metabolic monitoring devices - CGM, BGM or BKM - is far more than a procurement checkbox. The devices you choose directly impact patient compliance, data quality, and trial completion rates.
Yet this decision is often made on specifications alone, missing the bigger picture: patient experience, global logistics, integration, and support infrastructure.
What decision-makers should consider when selecting metabolic monitoring devices
When you're evaluating CGM, BGM or BKM solutions for your trial, move beyond the specification sheet. Ask these critical questions:
1. How user-friendly Is this device for your patient population?
A device that's intuitive for a tech-savvy 35-year-old may be a barrier for a 70-year-old. Similarly, a paediatric trial needs devices that work for children who may have anxiety about finger sticks or sensor insertions.
The best metabolic monitoring devices:
- Have minimal training requirements
- Feature clear, visual feedback (not just numerical readouts)
- Come with straightforward insertion or application processes
- Include patient-friendly educational materials (not just clinical documentation)
Ask your device supplier: Can you provide patient feedback data from similar trials? What's the actual learning curve we should expect?
2. Does the device support real-time data access and patient engagement?
In 2026, isolated devices are a liability. Leading CGMs and digital monitoring platforms now integrate with patient apps that show:
- Real-time glucose trends (for CGMs)
- Historical data and patterns
- In-app messaging between patient and coordinator
- Push notifications for adherence reminders
This isn't fluff - it's a retention tool. Patients who can see their own data in real time, who receive gentle reminders, and who feel supported by their coordinator through the app are significantly more likely to remain engaged.
3. What's the regulatory and availability status across your trial geography?
For global trials, this is non-negotiable. Some CGMs are FDA-approved but not CE-marked for European sites. Some are available in the US but require special import documentation for other regions. Others have supply chain vulnerabilities in specific markets.
A true partner in metabolic device supply understands:
- Regulatory pathways in each geography you're operating
- Import/export requirements and timelines
- Regional device availability and lead times
- Site-specific training and support needs
Misalignment here costs you weeks in timeline and thousands in expedited logistics.
4. What's the Quality Assurance and support infrastructure?
Like any medical device ecosystem, metabolic monitoring systems benefit from proactive support and rapid response protocols. The real differentiator isn't avoiding issues entirely - it's how quickly and effectively your partner resolves them.
Best-in-class suppliers provide:
- Pre-calibrated, quality-assured devices shipped directly to sites
- 24/7 technical support for sites and patients
- Rapid replacement protocols for device failures
- Proactive monitoring for known issues or firmware updates
- Clear escalation paths for urgent problems
5. Does your supplier understand your specific therapeutic area?
CGM technology in a Type 1 diabetes trial is very different from CGM in a GLP-1 weight loss trial. The clinical context, patient expectations, and data interpretation all differ. BGM in a hypertension trial has different requirements than in a diabetes trial.
A partner who understands your therapeutic area can:
- Recommend devices proven in similar studies
- Anticipate common patient questions and concerns
- Provide site training that speaks the language of your study population
- Offer insights on adherence patterns specific to your indication
How Woodley Trial Solutions can help
At Woodley Trial Solutions, we are long-term suppliers of metabolic monitoring devices to clinical trials globally. We're authorized distributors of leading CGM, BGM, and BKM solutions, and we manage the full lifecycle—from expert sourcing and regulatory navigation to site-ready delivery, 24/7 technical support, and end-to-end Project Management.
We understand that device selection is never one-size-fits-all. We partner with you to recommend best-fit solutions for your therapeutic area and patient population, manage complex global logistics, provide tailored training, and ensure rapid technical support when issues arise.
The bottom line
Device selection impacts patient engagement, data quality, and trial success. Think beyond specifications. Consider patient experience, geographic complexity, integration needs, and support infrastructure.
Share
